FeedbackBedaquiline should be included in longer MDR-TB regimens for patients aged 18 years or more. Bedaquiline may also be included in longer MDR-TB regimens for patients aged 6–17 years.
Guideline Citation
WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
Recommendation Direction